[3H]BHDP as a novel and selective ligand for σ1 receptors in liver mitochondria and brain synaptosomes of the rat

FEBS Letters

Volumn 553, Issue 1-2, 2003, Pages 157-162

  Klouz, Anis ^a   Tillement, Jean Paul ^a   Boussard, Marie Françoise ^b   Wierzbicki, Michel ^b   Berezowski, Vincent ^c   Cecchelli, Roméo ^c   Labidalle, Serge ^d   Onténiente, Brigitte ^a   Morin, Didier ^a,e  

^a FACULTÉ DE MÉDECINE   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c UNIVERSITÉ D'ARTOIS   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e CNRS   (France)

Author keywords

Astrocyte; Binding; Hypoxia; Liver mitochondrion; Synaptosome; Receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; N BENZYL N' (2 HYDROXY 3,4 DIMETHOXYBENZYL)PIPERAZINE H 3; PIPERAZINE DERIVATIVE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BINDING AFFINITY; BINDING SITE; BRAIN SYNAPTOSOME; CELL CULTURE; CELL DAMAGE; HYPOXIA; IN VITRO STUDY; ISOTOPE LABELING; LIVER MITOCHONDRION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; SYNAPTIC MEMBRANE;

EID: 0141794482     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)01011-1     Document Type: Article

References (25)

1. Bowen W.D. Pharm. Acta Helv. 74:2000;211-218.
2. Quirion R., Bowen W.D., Itzahk Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.C. Trends Pharmacol. Sci. 13:1992;85-86.
3. DeHaven-Hudkins D.L., Lanyon L.F., Ford-Rice F.Y., Ator M.A. Biochem. Pharmacol. 47:1994;1231-1239.
4. Cagnotto A., Bastone A., Mennini T. Eur. J. Pharmacol. 266:1994;131-138.
5. Mccann D.J., Weissman A.D., Su T.P. Synapse. 17:1994;182-189.
6. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., Maurice T. Neuroscience. 97:2000;155-170.
7. Klouz A., Sapena R., Liu J., Maurice T., Tillement J.P., Papadopoulos V., Morin D. Br. J. Pharmacol. 135:2002;1607-1615.
8. Balijepalli S., Kenchappa R.S., Boyd M.R., Ravindranath V. Neurochem. Int. 38:2001;425-435.
9. Karbon E.W., Patch R.J., Pontecorvo M.J., Ferkany J.W. Eur. J. Pharmacol. 176:1990;247-248.
10. Whittemore E.R., Ilyin V.I., Woodward R.M. J. Pharmacol. Exp. Ther. 282:1997;326-338.
11. Matsuno K., Nakazawa M., Okamoto K., Kawashima Y.A., Mita S. Eur. J. Pharmacol. 306:1996;271-279.
12. Berardi F., Ferorelli S., Colabufo N.A., Leopoldo M., Perrone R., Tortorella V. Bioorg. Med. Chem. 9:2001;1325-1335.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 93:1951;265-275.
14. Booher J., Sensenbrenner M. Neurobiology. 1972:1972;97-105.
15. Urien S. Pharm. Res. 12:1995;1225-1230.
16. Morin D., Zini R., Urien S., Sapena R., Tillement J.P. J. Receptor Res. 12:1992;369-387.
17. Bowen W.D., Hellewell S.B., McGarry K.A. Eur. J. Pharmacol. 163:1989;309-318.
18. O'Neill M., Caldwell M., Earley B., Canney M., O'Halloran A., Kelly J., Leonard B.E., Junien J.L. Eur. J. Pharmacol. 283:1995;217-225.
19. Maurice T., Lockhart B.P. Prog. Neuropsychopharmacol. Biol. Psychiat. 21:1997;69-102.
20. Nakazawa M., Matsuno K., Mita S. Neurochem. Int. 32:1998;337-343.
21. Harukuni I., Bhardwaj A., Shaivitz A.B., DeVries A.C., London E.D., Hurn P.D., Traystman R.J., Kirsch J.R., Faraci F.M. Stroke. 31:2000;976-982.
22. Lobner D., Lipton P. Neurosci. Lett. 117:1990;169-174.
23. DeCoster M.A., Klette K.L., Knight E.S., Tortella F.C. Brain Res. 671:1995;45-53.
24. Lesage A.S., De Loore K.L., Peeters L., Leysen J.E. Synapse. 20:1995;156-164.
25. Gonzalez-Alvear G.M., Werling L.L. J. Pharmacol. Exp. Ther. 271:1994;212-219.